Loading...
| A03185 | Pages: NA | Dec 2021 | 4663 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Chinese Patent Medicine Market
Request Now !Chinese patent medicines refer to herbal medicines, mainly extracted condensed pills called teapills, which are usually small, spherical, and black. Patents may come for various types of medicines such as syrups, dripping pills, liquids, capsules, powders, granules, and instant teas, which are manufactured by Chinese companies and exported within and outside China.
The major factors that contribute to the growth of the Chinese patent medicines market include the increasing prevalence of cardiovascular & cerebrovascular diseases, rise in health concerns among people, rising popularity of Chinese patent medicine with less toxicity & fewer side effects, and high demand for traditional Chinese medicine among patients. However, heavy metal contamination and stringent government regulations for prohibited ingredients may restrain the market. The development of drugs with less metal contamination and increasing ageing population presents a major opportunity for the market growth.
The Chinese patent medicines market is segmented on the basis of disease type, dosage forms, end user, and region. Based on disease type, the market is divided into cardiovascular & cerebrovascular diseases, tumor diseases, respiratory system diseases, musculoskeletal diseases, digestive system diseases, and others. On the basis of dosage form the market is segmented into injection, capsule, pills, syrups, and others. According to end user, the market is divided into hospitals, pharmacies or drugstores, and others.
The key players that operate in this market include Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Yangtze River Pharmaceutical (Group) Co., Ltd., China Resources Pharmaceutical Group Limited, Shanghai Pharmaceutical Co., Ltd., Taiji Group Co., Ltd., Tasly.Phar. International Co., Ltd., Yunnan Baiyao Group Co., Ltd., Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., Shandong Dong-E E-Jiao Co., Ltd., and Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 CHINESE PATENT MEDICINE MARKET, BY DISEASE TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. TUMOR DISEASES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. RESPIRATORY SYSTEM DISEASES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. MUSCULOSKELETAL DISEASES
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. DIGESTIVE SYSTEM DISEASES
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 CHINESE PATENT MEDICINE MARKET, BY DOSAGE FORM
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INJECTION
5.2.1. Market size and forecast
5.3. CAPSULE
5.3.1. Market size and forecast
5.4. PILLS
5.4.1. Market size and forecast
5.5. SYRUPS
5.5.1. Market size and forecast
5.6. OTHERS
5.6.1. Market size and forecast
CHAPTER 6 CHINESE PATENT MEDICINE MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. PHARMACIES OR DRUGSTORES
6.3.1. Market size and forecast
6.4. OTHERS
6.4.1. Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. SHANGHAI PHARMACEUTICAL CO., LTD.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. TAIJI GROUP CO., LTD.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. TASLY.PHAR. INTERNATIONAL CO., LTD.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. YUNNAN BAIYAO GROUP CO., LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. SHANDONG DONG-E E-JIAO CO., LTD.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. TIBET RHODIOLA PHARMACEUTICAL HOLDING CO., LTD.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
